86287682 - SAMIRNA

Information

• Trademark
• 86287682

• Source

• Serial Number

  86287682

• Registration Number

  5052167

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 5 - Pharmaceutical and veterinary preparations
  • 10 - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth
  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  May 21, 2014
  10 years ago

• Registration Date

  October 04, 2016
  8 years ago

• Transaction Date

  November 08, 2022
  2 years ago

• Status Date

  October 05, 2022
  2 years ago

• Published for Opposition Date

  July 19, 2016
  8 years ago

• Location Date

  October 05, 2022
  2 years ago

• Status Code

  704

• Employee Name

  KING, CHRISTINA B

• Attorney Docket Number

  OTB-158TM

  Attorney Name

  Jun-Hwa Jeong

  Law Office Assigned Location Code

  L90

• Owners

  • BIONEER CORPORATION

Case File Statements

• GS0051: Pharmaceutical preparations for the treatment of cancer, tumor, respiratory disease, immunization disease, skin disease, viral disease, allergies; Biological preparations for the treatment of cancer, tumor, respiratory disease, immunization disease, skin disease, viral disease, allergies; Medicated vaccines and serums for treatment of cancer, tumor, respiratory disease, immunization disease, skin disease, viral disease, allergies; Capsules sold empty for pharmaceutical purposes for the treatment of cancer, tumor, respiratory disease, immunization disease, skin disease, viral disease, allergies; Microspheres containing pharmaceutical preparations, for treating cancer, tumor, respiratory disease, immunization disease, skin disease, viral disease, allergies; Preparations and substances for facilitating delivery of pharmaceutical preparations, namely, drug delivery agent in the form of nanoparticle for transferring siRNA in the cell; Carriers for drug delivery, namely, drug delivery agent in the form of nanoparticle for transferring siRNA in the cell; Peptides for drug delivery, namely, drug delivery agents consisting of peptides attached to drugs that facilitate delivery of pharmaceutical preparations; Pharmaceutical preparations applied pharmaceutical drug delivery system, namely, elixirs for the treatment of cancer, tumor, respiratory disease, immunization disease, skin disease, viral disease, allergies and a nanoparticle carrier for transferring siRNA in the cell or peptide; Chemical reagents for medical use; Pharmaceutical preparations for drug delivery into cells; Drug delivery formulations, namely, compositions consisting of nanoparticle for transferring siRNA in the cell or peptides; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals for medical purpose; Pharmaceutical preparations and substances for facilitating drug delivery in the form of nanoparticle for transferring siRNA in the cell or peptide for use in medical treatment via inhibition of gene expression; Pharmaceutical preparations containing RNA for use in medical treatment via inhibition of gene expression; Pharmaceutical preparations containing DNA for use in medical treatment via inhibition of gene expression
• GS0011: Diagnostic preparations for research use; Reagents for scientific research use; Chemicals for laboratory analyses, other than for medical use, namely, chemicals for use in biotechnological product development; Chemicals for pharmaceutical purposes, namely, for use in the manufacture of drugs and medicines; Chemicals for the manufacture of medical products in the nature of pharmaceutical preparations; Biochemicals, namely, biochemical reagents used for non-medical purposes; Chemical preparations for the manufacture of medical products
• GS0101: [ Drug delivery system; Implantable drug syringes for drug delivery devices; Implantable drug delivery pumps for drug delivery devices; Medical apparatus for introducing pharmaceutical preparations into the human body; Medical apparatus for facilitating the inhalation of pharmaceutical preparations; Injection device for pharmaceuticals; Microspheres, namely, unilaminar and bilaminar spherical particles comprising hydrophilic and hydrophobic polymers with diameters in the nanometer range used as a means for drug delivery for treating cancer, tumor, respiratory disease, immunization disease, skin disease, viral disease, allergies ]
• GS0421: Pharmaceutical products research; Pharmaceutical products development; Research for medical products; Crude medicines research; Research and development of biotechnology for others; Quality control, namely, quality control of target gene expression activity with siRNA; Biotechnology research

Case File Event Statements

• 10/5/2022 - 2 years ago

  42 - NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED Type: NAS8

• 10/5/2022 - 2 years ago

  41 - REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED Type: 8.PR

• 10/4/2022 - 2 years ago

  40 - CASE ASSIGNED TO POST REGISTRATION PARALEGAL Type: APRE

• 4/26/2022 - 2 years ago

  39 - TEAS SECTION 8 RECEIVED Type: ES8R

• 10/4/2021 - 3 years ago

  38 - COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Type: REM1

• 10/4/2016 - 8 years ago

  37 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 7/19/2016 - 8 years ago

  36 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 7/19/2016 - 8 years ago

  35 - PUBLISHED FOR OPPOSITION Type: PUBO

• 6/29/2016 - 8 years ago

  34 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 6/15/2016 - 8 years ago

  33 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV

• 6/8/2016 - 8 years ago

  32 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 6/8/2016 - 8 years ago

  31 - EXAMINER'S AMENDMENT ENTERED Type: XAEC

• 6/8/2016 - 8 years ago

  30 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN

• 6/8/2016 - 8 years ago

  29 - EXAMINERS AMENDMENT E-MAILED Type: GNEA

• 6/8/2016 - 8 years ago

  28 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA

• 5/21/2016 - 8 years ago

  27 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 5/20/2016 - 8 years ago

  26 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 5/20/2016 - 8 years ago

  25 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 11/23/2015 - 9 years ago

  24 - NOTIFICATION OF PRIORITY ACTION E-MAILED Type: GPRN

• 11/23/2015 - 9 years ago

  23 - PRIORITY ACTION E-MAILED Type: GPRA

• 11/23/2015 - 9 years ago

  22 - PRIORITY ACTION WRITTEN Type: CPRA

• 11/16/2015 - 9 years ago

  21 - DATA MODIFICATION COMPLETED Type: DMCC

• 11/16/2015 - 9 years ago

  20 - ASSIGNED TO LIE Type: ALIE

• 11/9/2015 - 9 years ago

  19 - ASSIGNED TO EXAMINER Type: DOCK

• 10/23/2015 - 9 years ago

  18 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 10/23/2015 - 9 years ago

  17 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 10/23/2015 - 9 years ago

  16 - TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Type: ERSI

• 8/21/2015 - 9 years ago

  15 - NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED Type: GNS2

• 8/21/2015 - 9 years ago

  14 - INQUIRY TO SUSPENSION E-MAILED Type: GNSI

• 8/21/2015 - 9 years ago

  13 - SUSPENSION INQUIRY WRITTEN Type: CNSI

• 2/6/2015 - 10 years ago

  12 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Type: GNS3

• 2/6/2015 - 10 years ago

  11 - LETTER OF SUSPENSION E-MAILED Type: GNSL

• 2/6/2015 - 10 years ago

  10 - SUSPENSION LETTER WRITTEN Type: CNSL

• 2/5/2015 - 10 years ago

  9 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 2/4/2015 - 10 years ago

  8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 2/4/2015 - 10 years ago

  7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 8/4/2014 - 10 years ago

  6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 8/4/2014 - 10 years ago

  5 - NON-FINAL ACTION E-MAILED Type: GNRT

• 8/4/2014 - 10 years ago

  4 - NON-FINAL ACTION WRITTEN Type: CNRT

• 8/4/2014 - 10 years ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 6/4/2014 - 10 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS

• 5/24/2014 - 10 years ago

  1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP